Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Frontiers in Public Health
|
June 24, 2021
Just "Like Coffee" or Neuroenhancement by Stimulants?
Andreas G Franke, Gabriele Koller, Daniela Krause, et al.
Clinical EEG and Neuroscience
|
November 28, 2018
Event-Related Potentials Are Associated With Unexpected Gain and Loss: Using a Gambling Paradigm
Daniela Krause, Andrea Jobst, Shari Marie Langemak, et al.
Experimental and Clinical Psychopharmacology
|
May 23, 2022
Binding potential changes of SERT in patients with depression are associated with remission: A prospective [¹²³I]β-CIT-SPECT study
Daniela Krause, Agnieszka Chrobok, Susanne Karch, et al.
European Addiction Research
|
November 14, 2018
The Impact of the Opioid Antagonist Naloxone on Experimentally Induced Craving in Nicotine-Dependent Individuals
Daniela Krause, Marc Warnecke, Christian G Schuetz, et al.
Schizophrenia Research
|
June 24, 2010
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
Norbert Müller, Daniela Krause, Sandra Dehning, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
January 29, 2019
Values of Cytokines and Tryptophan Metabolites over a 12 Weeks Time Course in Patients with Depression and Somatoform Disorder
Daniela Krause, Verena B Kirnich, Theresa M Stapf, et al.
Psychiatry Research
|
October 20, 2019
Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence
Lisa Proebstl, Daniela Krause, Felicia Kamp, et al.
Substance Use & Misuse
|
February 4, 2017
High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment
Daniela Krause, Diana Plörer, Gabriele Koller, et al.
Neuroimmunomodulation
|
June 13, 2018
Stability of Cellular Immune Parameters over 12 Weeks in Patients with Major Depression or Somatoform Disorder and in Healthy Controls
Daniela Krause, Theresa M Stapf, Verena B Kirnich, et al.
World Journal of Psychiatry
|
September 2, 2022
Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users
Nina Behle, Felicia Kamp, Lisa Proebstl, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Frontiers in Public Health
|
June 24, 2021
Just "Like Coffee" or Neuroenhancement by Stimulants?
Andreas G Franke, Gabriele Koller, Daniela Krause, et al.
Clinical EEG and Neuroscience
|
November 28, 2018
Event-Related Potentials Are Associated With Unexpected Gain and Loss: Using a Gambling Paradigm
Daniela Krause, Andrea Jobst, Shari Marie Langemak, et al.
Experimental and Clinical Psychopharmacology
|
May 23, 2022
Binding potential changes of SERT in patients with depression are associated with remission: A prospective [¹²³I]β-CIT-SPECT study
Daniela Krause, Agnieszka Chrobok, Susanne Karch, et al.
European Addiction Research
|
November 14, 2018
The Impact of the Opioid Antagonist Naloxone on Experimentally Induced Craving in Nicotine-Dependent Individuals
Daniela Krause, Marc Warnecke, Christian G Schuetz, et al.
Schizophrenia Research
|
June 24, 2010
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
Norbert Müller, Daniela Krause, Sandra Dehning, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
January 29, 2019
Values of Cytokines and Tryptophan Metabolites over a 12 Weeks Time Course in Patients with Depression and Somatoform Disorder
Daniela Krause, Verena B Kirnich, Theresa M Stapf, et al.
Psychiatry Research
|
October 20, 2019
Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence
Lisa Proebstl, Daniela Krause, Felicia Kamp, et al.
Substance Use & Misuse
|
February 4, 2017
High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment
Daniela Krause, Diana Plörer, Gabriele Koller, et al.
Neuroimmunomodulation
|
June 13, 2018
Stability of Cellular Immune Parameters over 12 Weeks in Patients with Major Depression or Somatoform Disorder and in Healthy Controls
Daniela Krause, Theresa M Stapf, Verena B Kirnich, et al.
World Journal of Psychiatry
|
September 2, 2022
Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users
Nina Behle, Felicia Kamp, Lisa Proebstl, et al.
Page
of 4